Isomorphic Labs, a London-based company that applies AI to drug discovery, has obtained $5 billion in Series C. In the weekly ranking presented separately from this international operation, Science comes first with $400 million, ahead of Model ML.
Science and Model ML at the top of the ranking
Based in Alameda, California, Science focuses on brain-computer interfaces and neural engineering. Its series D brings the capital raised since its creation beyond 900 million dollars. Model ML, which offers an AI platform to financial and professional services, has completed a $250 million Series B round, led by General Atlantic and QED Investors. Present in both New York and London, this three-year-old company has a valuation of $1.5 billion.
Redwood City, Calif.-based Galvanize Therapeutics secures $130 million Series D round, with HealthQuest Capital leading the deal. Its pulsed electric field ablation technologies target oncology as well as chronic diseases.
General Flash, for its part, announces $128 million raised from numerous investors in seed and Series A rounds. The company is developing a new process to produce critical metals. Next comes Ramon.Space, a specialist in spatial computing infrastructures based in Denver. Its Series B reached $124 million, led by PSG.
The evening letterFree · 7 p.m.
AI transforming business?
AI strategies, movements and tricks deciphered, every evening in 5 minutes. Free.
Included upon registration: our selection of the best AI guides & comparisons.
Choose your pace
Free · No spam · Unsubscribe in 1 click
From Marrow Therapeutics to Vincue
Marrow Therapeutics announces its launch with $173 million in series A and B. The second, led by Orbimed, represents $120 million; the first, led by Scion Life Sciences with venBio, reached $53 million. Based in Watertown, Massachusetts, the company develops bone marrow treatments for severe blood disorders.
Noeri starts with $110 million in initial funding led by Menlo Ventures. Founded by computer science professors from Stanford University and based in Palo Alto, it develops self-improving AI for businesses and researchers. In San Diego, Seawolf Therapeutics is emerging from its discretionary phase and announcing cumulative funding of $100 million. This biotechnology company is preparing a new DNA delivery platform; its main investors are Versant Ventures, MPM BioImpact as well as Novartis Venture Fund.
BrightAI Secures Additional $97 Million in Deal Led by Smith Point Capital. Based in Silicon Valley, it is developing a platform combining sensors, drones and robotics to continuously observe sectors with significant infrastructure, notably energy. Finally, Vincue is raising $93 million in growth capital, led by Wavecrest Growth Partners. The Kansas City company is developing a vehicle lifecycle intelligence platform.
Greenoaks and Sequoia fund Isomorphic Labs
Greenoaks and Sequoia Capital led the financing of Isomorphic Labs. The company has existed for five years and has, in addition to its London location, offices in Massachusetts and Switzerland.

